Literature DB >> 25693020

A double-edged sword against type 1 diabetes.

Agnes Lehuen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693020     DOI: 10.1056/NEJMcibr1414708

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Clinical trials for BET inhibitors run ahead of the science.

Authors:  Guillaume Andrieu; Anna C Belkina; Gerald V Denis
Journal:  Drug Discov Today Technol       Date:  2016-07-21

2.  BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell.

Authors:  Jude T Deeney; Anna C Belkina; Orian S Shirihai; Barbara E Corkey; Gerald V Denis
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.